SOFTFIL® PRECISION Micro-Cannula 22G/40mm

Manufacturing Information for Softfil Precision Micro-Cannula 22G/40mm

Softfil Precision Micro-Cannula 22G/40mm is manufactured by Soft Medical Aesthetics, a French company specialising in high-precision micro-cannulas for aesthetic medicine. 

The Softfil Precision Micro-Cannula range includes various sizes to accommodate different treatment areas and filler viscosities:

• Softfil Precision Micro-Cannula 22G/40mm: A versatile option ideal for medium-viscosity fillers used in facial contouring, tear trough correction, and lip augmentation. The 40mm length allows for controlled and even product distribution in targeted areas.
• Softfil Precision Micro-Cannula 22G/50mm: Similar to the 22G/40mm model but with a longer 50mm length, providing greater reach for treating larger facial areas such as the jawline and temples with fewer entry points.
• Softfil Precision Micro-Cannula 25G/40mm: A thinner cannula suited for lower-density fillers, ideal for delicate areas like the under-eye region (tear troughs) and superficial facial injections. The 40mm length ensures precision while reducing trauma.
• Softfil Precision Micro-Cannula 25G/50mm: A mid-length cannula designed for injecting fine to medium-thickness fillers in areas requiring precision and smooth product flow, such as the nasolabial folds and lips.
• Softfil Precision Micro-Cannula 25G/60mm: The longest 25G model, suitable for practitioners who need enhanced reach for large treatment areas. This cannula provides flexibility for cheek augmentation and skin hydration treatments with mesotherapy.
• Softfil Precision Micro-Cannula 30G/25mm: The thinnest cannula in the range, perfect for ultra-fine filler injections and mesotherapy. It is particularly useful for superficial treatments, fine lines, and delicate areas like the perioral region and crow’s feet.

Expected Benefits and Results of the Treatments

Using Softfil Precision Micro-Cannula 22G/40mm provides multiple benefits:

• Reduced trauma: Minimises bruising, swelling, and discomfort.
• Enhanced precision: Allows controlled filler placement.
• Increased patient comfort: Blunt-tip design lowers pain levels.
• Lower risk of vascular complications: Reduces chances of injecting into blood vessels.
• Smooth filler distribution: Ensures even and natural-looking results.
• Shorter recovery time: Less swelling and bruising mean faster healing.

Softfil Precision Micro-Cannula 22G/40mm Materials and Device Properties

Softfil Precision Micro-Cannula is designed with key materials to ensure safety and effectiveness.

Materials:

• Medical-grade stainless steel: Provides exceptional durability, sterility, and resistance to bending for safe, reliable injections. 
• Sterile hydrophilic coating: Minimises friction for effortless insertion, enhancing patient comfort and procedural accuracy.

Device properties:

• Blunt-tip design: Reduces tissue damage and vascular risks.
• Polished surface: Enhances gliding for smoother injection.
• Flexible structure: Allows multi-directional movement for precise filler placement.
• Graduation marks: Aids in depth control during injections.

Included Items or Accessories

Each package of Softfil Precision Micro-Cannula 22G/40mm cannulas and needles includes:

• A box of 20 sterile micro-cannulas: Ensures hygienic, single-use application.
• 20 pre-hole needles: Facilitates initial skin penetration before cannula insertion.
• Instructions and product information.

Application Method for Softfil Precision Micro-Cannula 22G/40mm

Softfil Precision Micro-Cannula 22G/40mm should be used by trained medical professionals following these steps:

Pre-procedure:

• Assess the patient’s suitability and treatment goals.
• Cleanse and disinfect the treatment area.
• Apply a local anaesthetic if necessary.

During procedure:

• Use a sharp needle to create a pre-hole for cannula entry.
• Insert the cannula through the entry point and guide it into the target area.
• Inject filler slowly while withdrawing the cannula to ensure even distribution.

After procedure:

• Gently massage the area to shape the filler.
• Provide aftercare instructions to the patient.

Guidelines for Proper Aftercare

After using Softfil Precision Micro-Cannula 22G/40mm, patients should follow these aftercare steps:

• Avoid touching or massaging the treated area for 24 hours.
• Stay away from excessive heat (sunbathing, saunas) for 48 hours.
• Refrain from strenuous exercise for 24 hours.
• Use a cold compress to reduce swelling if needed.
• Follow up with the practitioner if any concerns arise.

Duration of Softfil Precision Micro-Cannula 22G/40mm

Softfil Precision Micro-Cannula 22G/40mm is intended for single use only. On the other hand, the longevity of results depends on the product used, treatment area, individual patient factors, and desired outcomes.

Potential Risks and Side Effects

Softfil Precision Micro-Cannula 22G/40mm is designed to minimise complications, but like any medical device, it may still cause some side effects. Practitioners should be aware of potential risks and inform patients accordingly:

• Swelling and redness: Mild inflammation at the injection site is common and usually subsides within a few hours to days.
• Bruising: Small blood vessels may be affected, leading to temporary bruising. This risk is lower compared to sharp needles but still possible.
• Tenderness or discomfort: Some sensitivity in the treated area may occur post-procedure but typically resolves within a few days.
• Hematoma formation: Improper injection technique or excessive pressure may cause blood to collect under the skin.
• Infection: Although rare, improper sterilisation or aftercare can lead to bacterial infections at the injection site.
• Filler migration: If excessive pressure is applied or incorrect technique is used, the filler may shift from the intended area.
• Allergic reactions: Sensitivity to the filler product or the cannula material, though uncommon, may lead to irritation.
• Lump formation or irregularities: Uneven distribution of filler or inadequate massaging after injection may cause nodules.
• Vascular compromise: While micro-cannulas reduce the risk of intravascular injection, improper technique may still lead to vessel compression, causing delayed healing or tissue damage.
• Delayed inflammatory reactions: Some patients may experience swelling, redness, or firmness weeks after treatment due to immune response.
• Nerve irritation: If a cannula comes too close to a nerve, temporary tingling, numbness, or discomfort may occur.

Softfil Precision Micro-Cannula 22G/40mm Treatment Contraindications

Softfil Precision Micro-Cannula 22G/40mm is designed for safe and precise aesthetic procedures, but certain conditions may prevent its use. Practitioners should assess patients thoroughly before treatment for the following contraindications:

• Pregnancy and breastfeeding: The safety of dermal filler injections during pregnancy or lactation has not been established.
• Active skin infections or inflammation: Conditions such as acne, herpes simplex, or dermatitis in the treatment area increase the risk of complications.
• Autoimmune diseases: Patients with lupus, rheumatoid arthritis, or similar conditions may have unpredictable immune responses to fillers.
• Bleeding disorders or anticoagulant therapy: Increased risk of excessive bruising or hematoma formation due to impaired blood clotting.
• Severe allergies or hypersensitivity: Patients with a history of anaphylaxis or filler allergies may experience adverse reactions.
• Uncontrolled diabetes: Poor wound healing and increased infection risk make treatment unsafe for patients with unstable blood sugar levels.
• Compromised immune system: Conditions such as HIV or immunosuppressive treatments may increase infection risks.
• Recent cosmetic procedures: Patients who have undergone recent laser treatments, chemical peels, or other skin-resurfacing procedures may be at risk of irritation or delayed healing.
• Unrealistic expectations or psychological concerns: Patients with body dysmorphic disorder or unrealistic aesthetic goals may not be suitable candidates.
• History of keloid or hypertrophic scarring: Increased risk of abnormal healing responses in certain individuals.
• Neurological conditions: Disorders such as Bell’s palsy or multiple sclerosis may be affected by injectable treatments.
• Recent dermal filler treatments in the same area: Overcorrection, uneven distribution, or filler migration may occur if additional filler is introduced too soon.
• Skin hypersensitivity or compromised barrier function: Conditions such as rosacea or eczema can make the skin more reactive to injection trauma.